RXO Net Worth

RXO Net Worth Breakdown

  RXO
The net worth of RXO Inc is the difference between its total assets and liabilities. RXO's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of RXO's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. RXO's net worth can be used as a measure of its financial health and stability which can help investors to decide if RXO is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in RXO Inc stock.

RXO Net Worth Analysis

RXO's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including RXO's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of RXO's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform RXO's net worth analysis. One common approach is to calculate RXO's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares RXO's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing RXO's net worth. This approach calculates the present value of RXO's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of RXO's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate RXO's net worth. This involves comparing RXO's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into RXO's net worth relative to its peers.
To determine if RXO is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding RXO's net worth research are outlined below:
RXO Inc generated a negative expected return over the last 90 days
RXO Inc has high historical volatility and very poor performance
The company reported the last year's revenue of 4.55 B. Reported Net Loss for the year was (285 K) with profit before taxes, overhead, and interest of 783 M.
RXO Inc has about 98 M in cash with (12 M) of positive cash flow from operations.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Wells Fargo Company Has Lowered Expectations for RXO Stock Price

RXO Quarterly Good Will

1.12 Million

RXO uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in RXO Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to RXO's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
8th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

RXO Target Price Consensus

RXO target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. RXO's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   18  Hold
Most RXO analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand RXO stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of RXO Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

RXO Target Price Projection

RXO's current and average target prices are 14.16 and 27.00, respectively. The current price of RXO is the price at which RXO Inc is currently trading. On the other hand, RXO's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

RXO Market Quote on 7th of April 2025

Low Price13.77Odds
High Price15.25Odds

14.16

Target Price

Analyst Consensus On RXO Target Price

Low Estimate24.57Odds
High Estimate29.97Odds

27.0

Historical Lowest Forecast  24.57 Target Price  27.0 Highest Forecast  29.97
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on RXO Inc and the information provided on this page.

Know RXO's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as RXO is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading RXO Inc backward and forwards among themselves. RXO's institutional investor refers to the entity that pools money to purchase RXO's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Charles Schwab Investment Management Inc2024-12-31
2.1 M
Dimensional Fund Advisors, Inc.2024-12-31
M
Frontier Capital Management Co Inc2024-12-31
M
Wellington Management Company Llp2024-12-31
M
Ubs Group Ag2024-12-31
1.9 M
Fred Alger Management, Llc2024-12-31
1.7 M
Franklin Resources Inc2024-12-31
1.7 M
Northern Trust Corp2024-12-31
1.6 M
Driehaus Capital Management Llc2024-12-31
1.5 M
Orbis Allan Gray Ltd2024-12-31
30.2 M
Mfn Partners Management, Lp2024-12-31
27.6 M
Note, although RXO's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow RXO's market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 2.37 B.

Market Cap

0.0

Project RXO's profitablity

Last ReportedProjected for Next Year
Return On Capital Employed(0.02)(0.02)
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income.
When accessing RXO's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures RXO's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of RXO's profitability and make more informed investment decisions.

Evaluate RXO's management efficiency

As of the 7th of April 2025, Return On Tangible Assets is likely to grow to -0.0002. In addition to that, Return On Capital Employed is likely to grow to -0.02. At this time, RXO's Other Assets are very stable compared to the past year. As of the 7th of April 2025, Intangible Assets is likely to grow to about 524 M, while Total Assets are likely to drop about 2.5 B. RXO's management efficiency ratios could be used to measure how well RXO manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 12.08  6.50 
Tangible Book Value Per Share(0.07)(0.07)
Enterprise Value Over EBITDA(20.37)(19.35)
Price Book Value Ratio 1.97  2.32 
Enterprise Value Multiple(20.37)(19.35)
Price Fair Value 1.97  2.32 
The management strategies employed by RXO's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Enterprise Value Revenue
0.6599
Revenue
4.6 B
Quarterly Revenue Growth
0.705
Revenue Per Share
34.105
Return On Equity
(0.26)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific RXO insiders, such as employees or executives, is commonly permitted as long as it does not rely on RXO's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases RXO insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

RXO Corporate Filings

2nd of April 2025
Other Reports
ViewVerify
F4
25th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
5th of March 2025
Other Reports
ViewVerify
10K
27th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
RXO time-series forecasting models is one of many RXO's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary RXO's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

RXO Earnings Estimation Breakdown

The calculation of RXO's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of RXO is estimated to be -0.0146 with the future projection ranging from a low of -0.04 to a high of 0.013. Please be aware that this consensus of annual earnings estimates for RXO Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.06
-0.04
Lowest
Expected EPS
-0.0146
0.01
Highest

RXO Earnings Projection Consensus

Suppose the current estimates of RXO's value are higher than the current market price of the RXO stock. In this case, investors may conclude that RXO is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and RXO's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
2175.23%
0.06
-0.0146
-2.17

RXO Earnings History

Earnings estimate consensus by RXO Inc analysts from Wall Street is used by the market to judge RXO's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only RXO's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

RXO Quarterly Gross Profit

1.67 Million

As of the 7th of April 2025, Price Earnings To Growth Ratio is likely to grow to 110.40, though Retained Earnings are likely to grow to (269.8 M). As of the 7th of April 2025, Common Stock Shares Outstanding is likely to drop to about 131.7 M. In addition to that, Net Income Applicable To Common Shares is likely to drop to about 95.4 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of RXO's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
10.4614.4818.50
Details
Intrinsic
Valuation
LowRealHigh
9.8813.9017.92
Details
18 Analysts
Consensus
LowTargetHigh
24.5727.0029.97
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.04-0.010.01
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of RXO assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards RXO. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving RXO's stock price in the short term.

RXO Earnings per Share Projection vs Actual

Actual Earning per Share of RXO refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering RXO Inc predict the company's earnings will be in the future. The higher the earnings per share of RXO, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

RXO Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as RXO, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of RXO should always be considered in relation to other companies to make a more educated investment decision.

RXO Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact RXO's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-06
2024-12-310.05770.060.0023
2024-11-07
2024-09-300.040.050.0125 
2024-08-07
2024-06-300.020.030.0150 
2024-05-02
2024-03-31-0.04-0.030.0125 
2024-02-08
2023-12-310.040.060.0250 
2023-11-07
2023-09-300.010.050.04400 
2023-08-02
2023-06-300.080.080.0
2023-05-03
2023-03-310.070.110.0457 
2023-02-07
2022-12-310.230.280.0521 
2022-11-30
2022-09-300.240.1118-0.128253 
2022-08-03
2022-06-3000.350.35

RXO Corporate Management

Jason KerrChief OfficerProfile
James HarrisChief OfficerProfile
Yoav AmielChief OfficerProfile
Lyndon CronSenior SalesProfile
When determining whether RXO Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of RXO's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rxo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rxo Inc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RXO Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Cargo Ground Transportation space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RXO. If investors know RXO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RXO listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.93)
Earnings Share
(2.17)
Revenue Per Share
34.105
Quarterly Revenue Growth
0.705
Return On Assets
0.0072
The market value of RXO Inc is measured differently than its book value, which is the value of RXO that is recorded on the company's balance sheet. Investors also form their own opinion of RXO's value that differs from its market value or its book value, called intrinsic value, which is RXO's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RXO's market value can be influenced by many factors that don't directly affect RXO's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RXO's value and its price as these two are different measures arrived at by different means. Investors typically determine if RXO is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RXO's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.